Divi's Laboratories Limited (BOM:532488)
8,056.65
+216.15 (2.76%)
At close: Jul 31, 2026
Divi's Laboratories Market Cap
Divi's Laboratories has a market cap or net worth of 2.14 trillion as of July 31, 2026. Its market cap has increased by 21.14% in one year.
Market Cap
2.14T
Enterprise Value
2.11T
Revenue
112.30B
Ranking
n/a
PE Ratio
73.12
Stock Price
8,056.65
ChartMarket Cap Chart
Since March 12, 2003, Divi's Laboratories's market cap has increased from 2.04B to 2.14T, an increase of 104,965.00%. That is a compound annual growth rate of 34.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 2.14T | 26.02% |
| Dec 31, 2025 | 1.70T | 4.82% |
| Dec 31, 2024 | 1.62T | 56.22% |
| Dec 29, 2023 | 1.04T | 14.38% |
| Dec 30, 2022 | 906.10B | -27.04% |
| Dec 31, 2021 | 1.24T | 21.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 244.64B |
| Shilpa Medicare | 119.61B |
| Suven Life Sciences | 80.99B |
| IOL Chemicals and Pharmaceuticals | 42.91B |
| Gujarat Themis Biosyn | 39.10B |
| Sai Parenteral's | 24.19B |
| NGL Fine-Chem | 20.22B |
| Bajaj HealthCare | 11.33B |